Indications
Prophylaxis of influenza in an officially declared pandemic situation. Pandemic-influenza vaccine should be used in accordance with official guidance.
Composition
- Active substance
- pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Pumarix
- Active substance
- pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
- ATC code
- J07BB02
- Therapeutic area
- Influenza, Human, Immunization, Disease Outbreaks
- Marketing authorisation holder
- GlaxoSmithKline Biologicals S.A.